CEB8- A DECISION ANALYTIC MODEL MEASURING THE COST-EFFECTIVENESS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN HIV PATIENTS WITH HIGH VERSUS LOW BASELINE VIRAL LOAD- AN INDINAVIR PLUS LAMIVUDINE ANDZIDOVUDINE EXAMPLE
Mar 1, 2000, 00:00 AM
10.1016/S1098-3015(11)70365-5
https://www.valueinhealthjournal.com/article/S1098-3015(11)70365-5/fulltext
Section Title :
Section Order :
217
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70365-5&doi=10.1016/S1098-3015(11)70365-5